J
Jennifer L. Cook
Researcher at University of Arizona
Publications - 21
Citations - 1024
Jennifer L. Cook is an academic researcher from University of Arizona. The author has contributed to research in topics: Heart failure & Medicine. The author has an hindex of 8, co-authored 17 publications receiving 653 citations. Previous affiliations of Jennifer L. Cook include Washington University in St. Louis & Medical University of South Carolina.
Papers
More filters
Journal ArticleDOI
Current Diagnostic and Treatment Strategies for Specific Dilated Cardiomyopathies: A Scientific Statement From the American Heart Association.
Biykem Bozkurt,Monica Colvin,Jennifer L. Cook,Leslie T. Cooper,Anita Deswal,Gregg C. Fonarow,Gary S. Francis,Daniel J. Lenihan,Eldrin F. Lewis,Dennis M. McNamara,Elfriede Pahl,Ramachandran S. Vasan,Kumudha Ramasubbu,Kismet Rasmusson,Jeffrey A. Towbin,Clyde W. Yancy +15 more
TL;DR: The intent of this American Heart Association (AHA) scientific statement is to summarize the current understanding of dilated cardiomyopathies, with special emphasis on recent developments in diagnostic approaches and therapies for specific cardiologyopathies.
Journal ArticleDOI
Antibody-mediated rejection in cardiac transplantation: emerging knowledge in diagnosis and management: a scientific statement from the American Heart Association.
Monica Colvin,Jennifer L. Cook,Patricia P. Chang,Gary S. Francis,Daphne T. Hsu,Michael S. Kiernan,Jon A. Kobashigawa,JoAnn Lindenfeld,Sofia Carolina Masri,Dylan V. Miller,John B. O'Connell,E. Rene Rodriguez,Bruce R. Rosengard,Sally E. Self,Connie White-Williams,Adriana Zeevi +15 more
TL;DR: The most recent International Society for Heart and Lung Transplantation (ISHLT) Consensus Conference on Antibody-Mediated Rejection (AMR) as discussed by the authors defined four diagnostic criteria: clinical, histopathologic, immunopathologic and serological assessment.
Journal ArticleDOI
Sensitization in Heart Transplantation: Emerging Knowledge: A Scientific Statement From the American Heart Association.
Monica Colvin,Jennifer L. Cook,Patricia P. Chang,Daphne T. Hsu,Michael S. Kiernan,Jon A. Kobashigawa,JoAnn Lindenfeld,S. Carolina Masri,Dylan V. Miller,E. Rene Rodriguez,Dolly B. Tyan,Adriana Zeevi +11 more
TL;DR: Although current strategies involve antibody suppression and removal with intravenous immunoglobulin, plasmapheresis, and antibody therapy, newer strategies with more specific targets are being investigated.
Journal ArticleDOI
Recommendations for the Use of Mechanical Circulatory Support: Ambulatory and Community Patient Care: A Scientific Statement from the American Heart Association
Jennifer L. Cook,Monica Colvin,Gary S. Francis,Kathleen L. Grady,Timothy M. Hoffman,Mariell Jessup,Ranjit John,Michael S. Kiernan,Judith E. Mitchell,Francis D. Pagani,Michael Petty,Pasala Ravichandran,Joseph G. Rogers,Marc J. Semigran,J. Matthew Toole +14 more
TL;DR: The aim of this document is to provide guidance for nonexperts in MCS and to facilitate the informed assessment, stabilization, and transport of the patient with MCS back to the MCS center for definitive therapy.
Journal ArticleDOI
Women With Cardiogenic Shock Derive Greater Benefit From Early Mechanical Circulatory Support: An Update From the cVAD Registry
Susan M. Joseph,Meredith A. Brisco,Monica Colvin,Kathleen L. Grady,Mary Norine Walsh,Jennifer L. Cook +5 more
TL;DR: Early initiation of hemodynamic support prior to PCI with Impella 2.5, in the setting of AMI complicated by CS, was associated with a greater survival benefit to hospital discharge in women compared to men, despite a higher predicted risk of mortality and a greater revascularization failure rate for women.